Company Overview of DSM Pharmaceutical Products, Inc.
DSM Pharmaceutical Products, Inc. provides custom contract manufacturing services to the pharmaceutical and biopharmaceutical industries. The company provides contract manufacturing services, including advanced intermediates, active ingredients, amino acids and derivatives, mammalian cell culture production of monoclonal antibodies, proteins, vaccines, finished dose manufacturing of solid dose products, scheduled drugs, liquids, aseptic liquid and lyophilized products, and solutions for chemicals needs. It also manufactures oral and topical dosage form products, including tablets, capsules, ointments, creams, and liquids. In addition, the company provides manufacturing technology and service...
45 Waterview Boulevard
Parsippany, NJ 07054-1298
Founded in 1990
Key Executives for DSM Pharmaceutical Products, Inc.
Chief Executive Officer of DSM Food Specialties and President of DSM Food Specialties
President of DSM Biologics and Business Unit Director of DSM Biologics
President of DSM Pharmaceuticals Inc and Business Unit Director of DSM Pharmaceuticals Inc
Chief Operating Officer of DSM Pharma Chemicals
Compensation as of Fiscal Year 2015.
DSM Pharmaceutical Products, Inc. Key Developments
DSM Pharmaceutical Products Opens $62 million Facility in Australia
Nov 14 13
DSM Pharmaceutical Products has opened a new bio-manufacturing facility in Australia, underpinning the nation's reputation for world-class medical innovation. The company said the plant would custom-make drugs on contract for local companies. The $62 million facility in the Queensland capital of Brisbane was built in partnership with Biopharmaceuticals Australia with co-operation from the Queensland Government and the Australian. The Brisbane facility provides contract manufacturing services from process development to commercial manufacturing. It specialises in cGMP mammalian cell culture, used in the development of medicines to treat cancer and other illnesses.
DSM Pharmaceutical Products, Inc. Opens New cGMP Facility for Biopharmaceutical Manufacturing in Brisbane, Australia
Oct 29 13
DSM Pharmaceutical Products, Inc. announced that it opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. The facility was designed by an expert international team of biological scientists and bioengineers, utilizing DSM's twenty seven years of experience in mammalian cell culture processing to construct a purpose-built, bio-manufacturing facility.
DSM Appoints Manja Bouman as President and Business Unit Director of Biopharm Businesses at DSM Pharmaceutical Products
Oct 24 13
Royal DSM announced the appointment of Dr. Manja Bouman Ph.D. as President and Business Unit Director of biopharm businesses at DSM Pharmaceutical Products. Dr. Bouman will head the DSM Biologics/BioSolutions businesses within the DSM Pharmaceutical Products business group of Royal DSM, as President and Business Unit Director effective 1 September 2013. Dr. Bouman will report to Lukas Utiger, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team. Dr. Bouman was most recently CEO of Regenesance B.V.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|